Apraclonidinum review

Apraclonidinum is commonly used in glaucoma therapy. This medication is most commonly known as Iopidine, though sometimes distributed as p-aminoclonidine. The medication is administered to patients when the current treatment is not enough to reduce eye pressure or to reduce eye pressure before and after surgery on the affected area.

Patients who want to reduce eye pressure or those who are planning to have laser eye surgery should use Apraclonidinum. The medication is commonly used as a means to prevent the rise of pressure that occurs within the eye during this type of surgical procedure.

Apraclonidinum is available in 0.5% and 1% solution. The 1% solution is commonly used before and after laser eye surgery; in most cases, one drop is administered before surgery and another drop afterwards. Doctors usually prescribe Apraclonidinum 0.5% for home use, while the 1% solution is released by the hospital before the procedure.

For glaucoma, when using Apraclonidinum 0.5%, medication is administered one drop in each eye 2 to 3 times a day for adults. For Apraclonidinum 1%, one drop is administered in the affected eye before and after surgery to prevent ocular hypertension. Use of both medicaments for children requires carefully following the prescription from the doctor.

Serious side effects of Apraclonidinum 0.5% and 1% include eye redness, pruritus, and tearing. In rare cases, the patient will suffer from blurred vision, disorientation, dizziness, depression, irregular heartbeat, redness of the eyelid, swelling, and breathing troubles. If you experience any of the above symptoms, seek immediate medical attention.

Common side effects include dryness of mouth, eye discomfort, and change in smell or taste, discoloration on the afflicted eye, runny nose, acute pharyngitis, sudden weaknesses, and sleeping troubles. These minor side effects often disappear after treatment and require no further prescription from the doctor. If you experience any of these symptoms, consult your doctor.

Patients taking MAO inhibitors should not use Apraclonidinum. Anti-depressants tend to lower the effectiveness of the medication, like its hypotensive effect. It is quite possible that use of such medication might reduce the IOP lowering effect of Apraclonidinum. Also, an added hypotensive effect was observed when patients use arpaclonidine with neuroleptic therapy.

Patients who are using Apraclonidinum 0.5% or 1% solution should have their vision checked periodically. The medication might cause some patients to suffer from dizziness, drowsiness, and being less alert. Those who are suffering from these symptoms must refrain from engaging in activities that might cause accidents or have fatal consequences. Using Apraclonidinum might also make your eyes more sensitive to sunlight; it is advisable to stay indoors or wear sunglasses to avoid further irritation or discomfort.

Apraclonidinum has the following structural formula:

Chemical structure of apraclonidinum

• Molecular formula of apraclonidinum is C9H10Cl2N4
• Chemical IUPAC Name is 2,6-dichloro-N-(4,5-dihydro-1H-imidazol-2-yl)benzene-1,4-diamine
• Molecular weight is 245.108 g/mol

Generic name: Apraclonidine

Brand name(s): Aplonidine, Apraclonidina, Iopidine

  Your Apraclonidinum review